We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
Public Sector Pension Investment Board (PSP Investments)
276
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$50.9M -$1.57M -49,960 -3%
TCM
277
Tetrem Capital Management
Manitoba, Canada
$50.8M +$24.2K +770 +0%
HM
278
HealthCor Management
New York
$50.7M -$36.6M -1,164,533 -41%
KBG
279
Kahn Brothers Group
New York
$50.7M -$3.35M -106,629 -6%
Jacobs Levy Equity Management
280
Jacobs Levy Equity Management
New Jersey
$49.9M +$3.89M +123,550 +8%
HI
281
Honeywell International
North Carolina
$49.4M +$2.66M +84,637 +6%
RAM
282
RWC Asset Management
United Kingdom
$49.2M +$1.22M +38,705 +2%
BNP Paribas Asset Management
283
BNP Paribas Asset Management
France
$48.5M +$4.67M +148,560 +10%
IRF
284
IBM Retirement Fund
New York
$48.4M +$252 +8 +0%
Connor, Clark & Lunn Investment Management (CC&L)
285
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$47.8M -$1.74M -55,335 -3%
VRS
286
Virginia Retirement Systems
Virginia
$47.3M +$9.82M +312,029 +25%
Envestnet Asset Management
287
Envestnet Asset Management
Illinois
$46.8M -$2.76M -87,815 -5%
SP
288
Sarasin & Partners
United Kingdom
$46.6M -$1.26M -40,089 -3%
MA
289
MUFG Americas
New York
$46.2M -$1.59M -50,540 -3%
DL
290
Delta Lloyd
Netherlands
$45.9M -$766K -24,337 -2%
NFC
291
Northeast Financial Consultants
Connecticut
$45.4M -$858K -27,261 -2%
GCM
292
Garland Capital Management
Washington
$45.2M -$818 -26 -0%
EIM
293
ExxonMobil Investment Management
Texas
$44.7M -$1.07M -33,885 -2%
CS
294
Candriam SCA
Luxembourg
$44.1M -$1.84M -58,421 -4%
HPC
295
HM Payson & Co
Maine
$43.7M +$3.28M +104,361 +8%
AAMU
296
AEGON Asset Management (UK)
United Kingdom
$43.6M -$14.6M -465,571 -25%
SIM
297
Sprucegrove Investment Management
Ontario, Canada
$43.4M -$18.1M -574,472 -29%
CIM
298
Confluence Investment Management
Missouri
$43.3M +$2.44M +77,613 +6%
SAM
299
Shell Asset Management
Netherlands
$43.3M -$15.4M -489,796 -26%
RJFSA
300
Raymond James Financial Services Advisors
Florida
$42.9M +$10.8M +344,368 +33%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.